Overview

Intranasal Dexmedetomidine Sedation for Pediatric CT Imaging

Status:
Unknown status
Trial end date:
2014-01-01
Target enrollment:
0
Participant gender:
All
Summary
This study has the objective to determine if intranasal dexmedetomidine, a sedative, is suitable for pediatric sedation in children undergoing tomographic scans.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Sao Paulo
Collaborators:
Boston Children's Hospital
Boston Children’s Hospital
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- Children between 1 month to 15 years old undergoing CT scans in the pediatric
emergency department

Exclusion Criteria:

- Glasgow coma scale < 13

- Epistaxis or suspected base skull fracture

- Use of contrast or need for an IV line before sedation

- Uncontrolled gastroesophageal reflux or vomiting

- Current (or within past 3 months) history of apnea of prematurity requiring an apnea
monitor

- Acute, unstable respiratory disease

- Unstable cardiac status

- Craniofacial anomaly

- Medication use: digoxin

- Moya Moya Disease

- New onset stroke

- American Society of Anesthesiologists physical status ≥3